NHS patients in England with a rare genetic disease that causes tumours in major organs, including the brain and spine, can now benefit from the first-ever therapy which could shrink their tumours to help them avoid high-risk surgery. In clinical trials of belzutifan, 95% of patients did not experience any growth in their tumours in […]
Read More on the NHS website.